Literature DB >> 9524291

Flow cytometric analysis of IL-6 receptors on peripheral lymphocytes in patients with primary biliary cirrhosis.

M Yamashiki1, Y Kosaka, J Nishioka, Y Tameda, K Takase, S Watanabe, M Kaito, A Nishimura, H Suzuki, M Nomoto.   

Abstract

Interleukin-6 receptors (IL-6R) and interleukin-1 receptors (IL-1R) on lymphocyte surfaces were analyzed, using flow cytometry and dye-labeled IL-6 and IL-1 beta, to examine the clinical and immunological significance of these receptors. Incubation of peripheral blood mononuclear cells in the presence of mitogen resulted in a remarkable increase of lymphocytes expressing the IL-6 and IL-1 beta receptors on the cell surface. The increase in lymphocytes bearing these cytokine receptors may reflect an increase in stimulated lymphocytes. When peripheral blood from patients with primary biliary cirrhosis (PBC) was examined for these receptors, the percentage of IL-6R positive cells was significantly higher in the patients than in healthy controls (P < 0.01). The increase in IL-6R positive cells was only significant for the T lymphocyte fraction (P < 0.01). No significant change in IL-1R was observed. There was a significant positive correlation between the percentage of IL-6R positive T lymphocytes and the titer of antimitochondrial antibody in patients with PBC. These findings concerning IL-6R may be noteworthy elucidating autoimmune etiological features of PBC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524291      PMCID: PMC6807960     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Molecular cloning and expression of an IL-6 signal transducer, gp130.

Authors:  M Hibi; M Murakami; M Saito; T Hirano; T Taga; T Kishimoto
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

2.  Simultaneous production of hepatic lesions and circulating antimitochondrial antibody in an experimental animal model of primary biliary cirrhosis.

Authors:  M Yamashiki; Y Kosaka; S Sakaguchi; F Ichida
Journal:  Gastroenterol Jpn       Date:  1990-02

3.  Two-color analysis of peripheral lymphocyte surface antigens in inherently healthy adults.

Authors:  M Yamashiki; A Nishimura; Y Kosaka; S P James
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

Review 4.  Cytokine signal transduction.

Authors:  T Kishimoto; T Taga; S Akira
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 5.  Human T-cell subsets in health and disease.

Authors:  S F Schlossman; E L Reinherz
Journal:  Springer Semin Immunopathol       Date:  1984

6.  There is more than one interleukin 1.

Authors:  J J Oppenheim; E J Kovacs; K Matsushima; S K Durum
Journal:  Immunol Today       Date:  1986-02

7.  Cloning the interleukin 1 receptor from human T cells.

Authors:  J E Sims; R B Acres; C E Grubin; C J McMahan; J M Wignall; C J March; S K Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  Interleukin 1 signaling occurs exclusively via the type I receptor.

Authors:  J E Sims; M A Gayle; J L Slack; M R Alderson; T A Bird; J G Giri; F Colotta; F Re; A Mantovani; K Shanebeck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignancies.

Authors:  E M Hersh; P W Mansell; J M Reuben; A Rios; G R Newell; A L Goldstein; K Lynch
Journal:  Diagn Immunol       Date:  1983

10.  Molecular cloning of the interleukin-1 beta converting enzyme.

Authors:  D P Cerretti; C J Kozlosky; B Mosley; N Nelson; K Van Ness; T A Greenstreet; C J March; S R Kronheim; T Druck; L A Cannizzaro
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

  10 in total
  2 in total

1.  Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system.

Authors:  X X Huang; M Yamashiki; K Nakatani; T Nobori; A Mase
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  A case of rheumatoid arthritis and limited systemic sclerosis overlap successfully treated with tocilizumab for arthritis and concomitant generalized lymphadenopathy and primary biliary cirrhosis.

Authors:  Eiko Saito; Shinji Sato; Shinichi Nogi; Noriko Sasaki; Naofumi Chinen; Kiri Honda; Takayuki Wakabayashi; Chiho Yamada; Naoya Nakamura; Yasuo Suzuki
Journal:  Case Rep Rheumatol       Date:  2014-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.